Jonathan C. P. Roos

Outrageous prices of orphan drugs: a call for collaboration

Lucio Luzzatto, Hanna I. Hyry, Arrigo Schieppati et al. · The Lancet · 2018 · 154 citations

Substance Abuse, Economics, Public Policy +9

A series of pregnancies in women with inherited metabolic disease

Janneke G. Langendonk, Jonathan C. P. Roos, Lindsay Angus et al. · Journal of Inherited Metabolic Disease · 2011 · 79 citations

T2-relaxation mapping and fat fraction assessment to objectively quantify clinical activity in thyroid eye disease: an initial feasibility study

Tilak Das, Jonathan C. P. Roos, Andrew J. Patterson et al. · Eye · 2018 · 62 citations · Full text

Ophthalmology, Physiology, Thyroid Disease +7

Orphan drug pricing may warrant a competition law investigation

Jonathan C. P. Roos, Hanna I. Hyry, Timothy M. Cox · BMJ · 2010 · 51 citations

Preclinical Therapeutics, Patent Prosecution, Exclusive Marketing Period +19

Serial TSH-receptor antibody levels to guide the management of thyroid eye disease: the impact of smoking, immunosuppression, radio-iodine, and thyroidectomy

Jonathan C. P. Roos, V. Paulpandian, Rachna Murthy · Eye · 2018 · 41 citations · Full text

Ophthalmology, Thyroid Disease, Immunology +7